Printer Friendly
The Free Library
14,559,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Teijin Pharma Introduces Compact CPAP Device.


Tokyo, Japan, Feb 14, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Teijin Pharma announced on February 13 that it has launched the AutoSet C, a continuous positive airway pressure continuous positive airway pressure
n.
Abbr. CPAP A technique of respiratory therapy for individuals breathing with or without mechanical assistance in which airway pressure is maintained above atmospheric pressure throughout the
 (APAP APAP Association of Performing Arts Presenters
APAP Association of Physician Assistant Programs
APAP Action Professionals' Association for the People
APAP Associação Portuguesa das Empresas de Publicidade e Comunicação (Portugal) 
) device, across Japan.

The AutoSet C, which is manufactured by Australian company ResMed, is used in the treatment of sleep apnea syndrome sleep apnea syndrome Ondine's curse A condition defined by frequent episodes of sleep apnea, hypopnea, and Sx of functional respiratory impairment; it is potentially life-threatening, and associated with daytime hypersomnolence, MVAs, and cardiovascular M&M in . It uses a memory card to monitor the usage to optimize the treatment process.

Easy to carry, the product weighs only 1.3 kg and measures 112x164x145mm. Since the AutoSet C is covered by the national health insurance, patients can use it for about 5,000 yen ($420) per month.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Feb 21, 2006
Words:107
Previous Article:Takeda Pharmaceutical, Affymax Conclude Licensing Agreement for Hematide, Renal/Malignant Anemia Treatment Agent.
Next Article:MBL International Acquires Antibody Business from LifeSpan BioSciences.



Related Articles
An overview of nasal CPAP therapy in the management of obstructive sleep apnea.
Lightweight CPAP mask.
CPAP device with humidification.
Bendable CPAP mask. (Product Marketplace).(Brief Article)
Comfort masks for CPAP. (Product Marketplace).(continuous positive airway pressure mask from SleepNet)(Brief Article)
Improved CPAP machines.(Product Marketplace)(Brief Article)
Teijin Pharma Launches New Compact CPAP Device for Sleep Apnea Syndrome Treatment.
Teijin Pharma Brings Tyco's CPAP Device GoodKnight 420 to Japan.
Teijin Pharma, Sato Pharmaceutical Jointly Introduce Antipsoriatic Agent Bonalfa.
Teijin Pharma Releases SAS Testing Device.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles